Moolec Science (MLEC) Income towards Parent Company (2022 - 2024)
Moolec Science's (MLEC) quarterly Income towards Parent Company came in at -$1.9 million in Q4 2024, up 17.29% year-on-year from -$1.6 million in Q1 2024, and up 5.37% quarter-over-quarter from -$2.0 million in Q3 2024.
Moolec Science (MLEC) Income towards Parent Company (2022 - 2024) Analysis & Trends
Moolec Science has disclosed Income towards Parent Company across 3 years of filings, most recently posting -$1.9 million for Q4 2024.
- Income towards Parent Company for Q4 2024 came in at -$1.9 million, up 17.29% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.9 million (changed N/A YoY), and the FY2024 annual result was -$32.9 million, down 181.3% from the prior year.
- Income towards Parent Company came in at -$1.9 million for Q4 2024 at Moolec Science, up from -$2.0 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $99.8 million in Q2 2023 to a low of -$32.9 million in Q2 2024.
- The 3-year median for Income towards Parent Company is -$1.5 million (2022), against an average of $8.1 million.
- Across the five-year window, Income towards Parent Company jumped 1610.88% in 2023 and tumbled 220.25% in 2024, its largest moves.
- Moolec Science's Income towards Parent Company stood at $48.0 million in 2022, then slumped by 104.7% to -$2.3 million in 2023, then gained by 17.29% to -$1.9 million in 2024.
- The last three Income towards Parent Company figures came in at -$1.9 million (Q4 2024), -$2.0 million (Q3 2024), and -$32.9 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.87 Mn |
| Sep 30, 2024 | -1.97 Mn |
| Jun 30, 2024 | -32.88 Mn |
| Mar 31, 2024 | -1.15 Mn |
| Dec 31, 2023 | -2.26 Mn |
| Sep 30, 2023 | -2.02 Mn |
| Jun 30, 2023 | 99.84 Mn |
| Mar 31, 2023 | -358,578.00 |
| Dec 31, 2022 | 47.96 Mn |
| Sep 30, 2022 | -721,426.00 |
| Jun 30, 2022 | -6.61 Mn |
| Mar 31, 2022 | -1.17 Mn |